The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

An Alzheimer's drug deemed the "best ever" is set to be blocked for NHS use due to its high cost. Donanemab, manufactured by ...

NHS patients are set to miss out on new Alzheimer’s drugs, experts warn ...

A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...

The treatment – one of two new drugs to target a cause of the disease – has been considered by the medicines regulator and the NHS spending watchdog. A decision is expected imminently. Donanemab, ...

The service screens for conditions such as Dementia, which is an umbrella term for progressive brain changes such as Alzheimer's Disease ... jointly provided by NELFT NHS Foundation Trust and the ...

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly and silently appears to lay the groundwork for a second, more widely ...

Oct. 16, 2024 — Researchers used mouse models and human post-mortem brain tissue to study the molecular underpinnings that may increase the risk of Alzheimer's after ... Alzheimer's Disease May ...

MOOSIC, Pa. — Alzheimer's Disease is a brain disorder that affects the memory. Millions of people are affected in some way. "About 280,000 people in Pennsylvania are going through an Alzheimer's ...